With The End Of Pfizergan, Pfizer Has To Grow It Alone
This article was originally published in The Pink Sheet Daily
Executive Summary
Investors are wondering what Pfizer might do next – and especially whether or not it will split – after the company is outmaneuvered by the US government and ends its ambition to merge with Allergan.